First published 9/30/2026, 4:14:15 AM · Last updated 9/30/2026, 4:14:29 AM

Tail approach synthesis of novel benzenesulfonamides incorporating 1,4-disubstituted triazole hybrids as potent inhibitors of carbonic anhydrase I, II, IX and XII isoenzymes

A peer-reviewed journal article reports the synthesis of new benzenesulfonamide compounds with 1,4-disubstituted triazole motifs that are described as potent inhibitors of carbonic anhydrase isoenzymes I, II, IX and XII. The publisher is Elsevier BV and the article was published on 2026-10-01.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The reported compounds are described as potent inhibitors of multiple carbonic anhydrase isoenzymes, which is relevant to biomedical research on those targets.

Sources

Tail approach synthesis of novel benzenesulfonamides incorporating 1,4-disubstituted triazole hybrids as potent inhibitors of carbonic anhydrase I, II, IX and XII isoenzymes

Report an issue